The CBR is pleased to announce that Talecris Canada has awarded the CBR an unrestricted Medical Education Grant of $10,000 to support the CBR Seminar Series. Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas. The CBR values Talecris as a partner in sustaining and expanding world-class educational opportunities.